Genprex Deferred Long Term Liab from 2010 to 2025
| GNPX Stock | USD 0.38 0.02 6.11% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 873.5 K | Current Value 917.2 K | Quarterly Volatility 394.1 K |
Check Genprex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genprex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 K, Interest Expense of 21.9 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.85. Genprex financial statements analysis is a perfect complement when working with Genprex Valuation or Volatility modules.
Genprex | Deferred Long Term Liab |
Latest Genprex's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Genprex over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Genprex's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genprex's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Genprex Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 455,401 | |
| Geometric Mean | 175,651 | |
| Coefficient Of Variation | 86.53 | |
| Mean Deviation | 376,158 | |
| Median | 759,591 | |
| Standard Deviation | 394,079 | |
| Sample Variance | 155.3B | |
| Range | 891.7K | |
| R-Value | 0.89 | |
| Mean Square Error | 34.6B | |
| R-Squared | 0.79 | |
| Slope | 73,666 | |
| Total Sum of Squares | 2.3T |
Genprex Deferred Long Term Liab History
About Genprex Financial Statements
Genprex investors use historical fundamental indicators, such as Genprex's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genprex. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 873.5 K | 917.2 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Genprex Stock Analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.